Literature DB >> 28358929

Update in Critical Care Medicine: Evidence Published in 2016.

Mark Hepokoski1, Atul Malhotra1.   

Abstract

Entities:  

Year:  2017        PMID： 28358929      PMCID： PMC5483325          DOI： 10.7326/M17-0138

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  37 in total

1.  Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial.

Authors:  M Antonelli; G Conti; M Bufi; M G Costa; A Lappa; M Rocco; A Gasparetto; G U Meduri
Journal:  JAMA       Date:  2000-01-12       Impact factor: 56.272

2.  Acute respiratory distress syndrome: underrecognition by clinicians.

Authors:  Stephen Fröhlich; Noelle Murphy; Aoife Doolan; Orla Ryan; John Boylan
Journal:  J Crit Care       Date:  2013-06-24       Impact factor: 3.425

3.  Mechanical ventilation in acute respiratory distress syndrome at ATS 2016: the search for a patient-specific strategy.

Authors:  Mark Hepokoski; Robert L Owens; Atul Malhotra; Jeremy R Beitler
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Neuromuscular blockers in early acute respiratory distress syndrome.

Authors:  Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

5.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.

Authors:  Jean-Pierre Frat; Arnaud W Thille; Alain Mercat; Christophe Girault; Stéphanie Ragot; Sébastien Perbet; Gwénael Prat; Thierry Boulain; Elise Morawiec; Alice Cottereau; Jérôme Devaquet; Saad Nseir; Keyvan Razazi; Jean-Paul Mira; Laurent Argaud; Jean-Charles Chakarian; Jean-Damien Ricard; Xavier Wittebole; Stéphanie Chevalier; Alexandre Herbland; Muriel Fartoukh; Jean-Michel Constantin; Jean-Marie Tonnelier; Marc Pierrot; Armelle Mathonnet; Gaëtan Béduneau; Céline Delétage-Métreau; Jean-Christophe M Richard; Laurent Brochard; René Robert
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

6.  A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

Authors:  Joel M Dulhunty; Jason A Roberts; Joshua S Davis; Steven A R Webb; Rinaldo Bellomo; Charles Gomersall; Charudatt Shirwadkar; Glenn M Eastwood; John Myburgh; David L Paterson; Therese Starr; Sanjoy K Paul; Jeffrey Lipman
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

7.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 8.  A Critical Care Societies Collaborative Statement: Burnout Syndrome in Critical Care Health-care Professionals. A Call for Action.

Authors:  Marc Moss; Vicki S Good; David Gozal; Ruth Kleinpell; Curtis N Sessler
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

9.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.